PAMINE FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Pamine Forte patents expire, and when can generic versions of Pamine Forte launch?
Pamine Forte is a drug marketed by Fougera Pharms and is included in one NDA.
The generic ingredient in PAMINE FORTE is methscopolamine bromide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pamine Forte
A generic version of PAMINE FORTE was approved as methscopolamine bromide by BRECKENRIDGE PHARM on December 6th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PAMINE FORTE?
- What are the global sales for PAMINE FORTE?
- What is Average Wholesale Price for PAMINE FORTE?
Summary for PAMINE FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 49 |
| Patent Applications: | 876 |
| DailyMed Link: | PAMINE FORTE at DailyMed |
US Patents and Regulatory Information for PAMINE FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | PAMINE FORTE | methscopolamine bromide | TABLET;ORAL | 008848-002 | Mar 25, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
